Skip to Content

Find Comparable ETFs for VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF

PPH - NGM
ETF Category
Health & Biotech Equities
Asset Class
Equity
AUM
$632M
Expense Ratio
0.36% (Low)
Trading Volume
126.5K (Moderate)
Issuer
VanEck
Number of Holdings
26
Inception Date
2011-12-20 (13 years)
Momentum
Very Weak Neutral Very Strong
AUM
Micro Small Very Large
Concentration
Very Low High Very High
Volatility
Very Low Very Low Very High
Overview
Momentum
Concentration
ESG
P/E Ratio
15.43
Annual Dividend Rate
1.63%
Beta
0.72
50-Day Moving Average
$88.76
Price vs. 50-Day MA
6.24%
200-Day Moving Average
$91.77
Price vs. 200-Day MA
2.76%
1 Year Fund Flow
$206M (33% of AUM)
3 Year Fund Flow
$222M (35% of AUM)
5 Year Fund Flow
$315M (50% of AUM)
% in Top 10 Holdings (Market Cap Weighted)
63.11%
% in Top 15 Holdings (Market Cap Weighted)
86.34%
% in Top 50 Holdings (Market Cap Weighted)
100.02%
ESG Score
7.1300
ESG Peer %
92.11
ESG Global %
76.20
Carbon Intensity (Tons CO2e/$M Sales)
16
ESG Exclusion %
0.00
Sustainable Impact %
16.98

Vanguard Health Care Index Fund ETF Shares

VHT - PCX
View VHT's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $18,155M
Expense Ratio: 0.09% (Very Low)
Volume: 143.3K (Moderate)
Issuer: Vanguard
Holdings: 419
Inception: 2004-01-26 (21 years)
Neutral Momentum
Large AUM
Very Low Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

The Invesco Pharmaceuticals ETF is concentrated on pharmaceutical companies, which are a significant part of the health care industry, making it a relevant comparison to VHT.

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 72%

R-squared: 53%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 4
  • PPH in VHT's comparables: Yes
  • VHT in PPH's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 15.43 vs 22.00

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A+

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • PPH Beta: 0.72 (Low)
  • VHT Beta: 0.73 (Low)
  • PPH 200-day Volatility: 9.58%
  • VHT 200-day Volatility: 10.58%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • PPH Price vs 200-day MA: 103%
  • VHT Price vs 200-day MA: 100%

Performance Comparison:

Period PPH VHT
Year_1 20% 15%
Year_3 10% 4%
Year_5 12% 11%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: NGM vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • PPH Dividend Yield: 2%
  • VHT Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
22.00
Annual Dividend Rate
1.28%
Beta
0.73
50-Day Moving Average
$264.61
Price vs. 50-Day MA
2.28%
200-Day Moving Average
$271.01
Price vs. 200-Day MA
-0.14%
1 Year Fund Flow
-$853M (-5% of AUM)
3 Year Fund Flow
$751M (4% of AUM)
5 Year Fund Flow
$3,074M (17% of AUM)
% in Top 10 Holdings
48%
% in Top 15 Holdings
59%
% in Top 50 Holdings
86%
ESG Score
6.5900
ESG Peer %
54.32
ESG Global %
52.52
Carbon Intensity
15
ESG Exclusion %
0.02
Sustainable Impact %
10.85
Toggle between similar ETFs and stocks for comparison.

Loading comparable ETFs ...

Vanguard Health Care Index Fund ETF Shares

VHT - PCX
A+
$270.64 -1.73 (-0.63%)
Health & Biotech Equities
Equity
AUM: $18,155M
Expense Ratio: 0.09% (Very Low)
Volume: 143.3K (Moderate)
Issuer: Vanguard
Holdings: 419
Inception: 2004-01-26 (21 years)
Neutral Momentum
Large AUM
Very Low Concentration
Low Volatility